Peter Pudselykke
Head of Investor Relations
Replay available
Demant As (OTC: WILLF) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Head of Investor Relations
President and CEO
CFO
Analyst at ASP
Analyst at Citi
Analyst at Nordea
Analyst at JP Morgan
Analyst at DNB Carnegie
Analyst at Goldman Sachs
Analyst at UBS
Analyst at Danske Bank
Analyst at Bernstein
Analyst at BNP Paribas
Analyst at Jefferies
Analyst at Deutsche Bank
Good afternoon everyone and welcome to the conference call for DEMAND's interim report for 2026. My name is Peter Pudselykke and I'm heading up the investor relations activities here in DEMAND. With me today I have our usual crew, our president and CEO Søren Nielsen, our CFO René Schneider, as well as one of my good colleagues in the IR team, Gustav Hoegh. As you should have seen by now, there were a couple of announcements out from us last night. One relating to the interim report, and one relating to the launch of our new premium hearing aid, Oticon Reveal. We will be discussing both during today's call, and we plan to kick off with a presentation, which will be followed up by a Q&A session. The total session is expected to last no more than one hour, and the presentation should be online by now. When we get to the Q&A, we kindly remind you to limit yourselves to two questions at a time, please, to allow as many as possible to ask a question. Before we dig into the presentation, please do pay notice to the disclaimer slide on slide two, and with that onto slide three, where I will leave it to Søren to start with the agenda, please. Thank you very much, Peter, and welcome everybody. Today's agenda, no surprise, highlights and financial takeaways, big business area review. René will take us through more details on the group financials. We'll discuss the outlook or present the revised outlook and take Q&A. And first half in highlights for Demand 2026, strong momentum in all business areas, ahead of expectation with growth accelerating from first quarter into second. This is driven by strong performance in hearing aids, where we, fueled by the success of Oticon Seal, have seen a further strengthening of the momentum. Market growth remains to be in line with what we saw...